Product1 publisher3 min readPublished
China's regulator is holding humanoid robot IPOs back until the revenue repeats
The Information reported that China's securities regulator is asking humanoid firms for recurring revenue and narrowing losses before they list. Exchange review materials show 73.6% of Unitree's revenue came from research and education buyers.
The Product Desk · Product desk
What happened
- China's securities regulator has begun steering humanoid robot companies away from the public markets until they can show recurring revenue and a credible path to narrowing losses, The Information reported on 9 September.
- Reuters reported that at least six Chinese humanoid firms preparing to list are now waiting, and that private-market valuations have been cut by 30% to 50%.
- Unitree listed on Shanghai's STAR Market on 19 August at 150.80 yuan a share and rose as much as 460% in one session, to a price-to-earnings ratio above 1,300 against a STAR average closer to 124.
- By the time the regulator's caution surfaced, Unitree sat roughly 55% below that peak, having already given up about 45% of it by 25 August.
Compiled by The Product DeskSomething wrong?How this is made
Why it matters
- constraint Until a supplier can show customers who order a second unit, its listing sits in the queue, so the work lands on whoever owns the industrial sales pipeline.
- exposure A buyer cannot easily diversify out of the affected cohort when Chinese manufacturers made more than 90% of global humanoid shipments in the first half of 2026.
- decision Anyone signing multi-year robotics supply is now pricing supplier risk against an unwritten rule, with nothing published to check and the caught firms unnamed.
- contradiction Reuters reports private marks down 30% to 50% and also reports a calculation implying 60% to 70% once unsustainable revenue is stripped, so the discount already taken may be the optimistic one.
A university lab buys one unit on a grant and does not order a second. Research and education buyers accounted for 73.6% of Unitree's revenue in the first nine months of 2025, against about 9% from industrial sales, according to review materials filed with the Shanghai Stock Exchange [9]. The research and education share is roughly eight times the industrial one [3]. The China Securities Regulatory Commission wants recurring revenue and a credible path to narrowing losses before a listing, The Information reported [1].
The 55% fall is measured from the intraday peak. Unitree priced at 150.80 yuan and rose as much as 460% in a session [5][6], and that peak is about 845 yuan [1]. Down 55% from there is roughly 380 yuan, about 2.5 times the issue price [2]. Buyers in the offering are still well ahead. Buyers of the pop are down by half.
At the peak the price-to-earnings ratio ran above 1,300, more than ten times the STAR Market average of about 124 [6][5]. Mech-Mind, which listed in Hong Kong on 1 September, is down around 20% from its debut-day high [8]. The wider window is still open: mainland share sales reached $148.9bn so far in 2026, up 59% year on year, with technology at 41% of the total [13]. Ruiying Zhao of S&P Global described the change to Reuters as a move from "blanket euphoria to selective rationality" [12].
Shao Tianlan, chief executive of Mech-Mind, told Reuters that some of the sector's revenue arrives through "data collection centers, related-party deals and other unsustainable arrangements" [10]. Reuters reported that stripping those out could cut some valuations by 60% to 70%, a calculation no other outlet has corroborated [11]. Private marks, per the same report, are down 30% to 50% [3]. Take the midpoints: a 40% cut leaves 60 cents of the old dollar and a 65% strip leaves 35, so the marked-down number still sits about 1.7 times above the stripped one [4].
Runway now depends on who closed when. LimX raised $200m in July on an explicitly pre-IPO footing, and XPENG's robotics arm took more than $900m in August ahead of its first production run [14]. Both landed before the guidance surfaced. The regulator has published nothing, and the six firms said to be waiting are unnamed [16].
For a team picking a humanoid supplier for a 2027 line, the question worth asking in the diligence call is how many customers bought a second unit for the same job, and what that second unit does all day. Chinese manufacturers shipped more than 90% of the world's humanoids in the first half of 2026 [15], so the supplier shortlist and the affected cohort are close to the same list. If the answer involves a data collection center or a related party, that is the revenue the regulator is discounting.
What to watch
- Whether the CSRC puts the guidance in writing or states conditions for humanoid listings publicly.
- Whether any of the six firms said to be waiting is named, or prices a listing anyway.
- Whether Unitree's next disclosure shows industrial sales above the 9% share in its exchange review materials.